Clinical trials
Radiation Injuries trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
| Completed | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Azienda Ospedaliero-Universitaria Careggi | 1 |
| CNAO National Center of Oncological Hadrontherapy | 1 |
| Catholic University of the Sacred Heart | 1 |
| Centro di Riferimento Oncologico - Aviano | 1 |
| European Institute of Oncology | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Gemelli Molise Hospital | 1 |
| IRCCS San Raffaele | 1 |
| Istituti Clinici Scientifici Maugeri SpA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Radiation Injuries | 12 |
| Breast Neoplasms | 4 |
| Head and Neck Neoplasms | 4 |
| Brain Neoplasms | 2 |
| Neoplasms | 2 |
| Disease Progression | 1 |
| Drug-Related Side Effects and Adverse Reactions | 1 |
| Esophageal Neoplasms | 1 |
| Genital Neoplasms, Female | 1 |
| Liver Neoplasms | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.